
Reset all filters
01 7Ajovy
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 93
2018 Revenue in Millions : 3
Growth (%) : 3,000
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 165
2019 Revenue in Millions : 96
Growth (%) : 72
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 313
2020 Revenue in Millions : 165
Growth (%) : 90
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 377
2021 Revenue in Millions : 313
Growth (%) : 20
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 434
2022 Revenue in Millions : 377
Growth (%) : 15
Main Therapeutic Indication : Neurology
Currency : USD
2024 Revenue in Millions : 507
2023 Revenue in Millions : 434
Growth (%) : 17
Main Therapeutic Indication : Neurology
Currency : USD
2024 Revenue in Millions : 39
2023 Revenue in Millions : 28
Growth (%) : 39